BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/26/2018 8:09:36 AM | Browse: 1025 | Download: 1877
 |
Received |
|
2017-09-29 00:19 |
|
Peer-Review Started |
|
2017-10-02 18:27 |
|
To Make the First Decision |
|
2017-11-23 02:19 |
|
Return for Revision |
|
2017-11-27 11:19 |
|
Revised |
|
2017-12-04 06:38 |
|
Second Decision |
|
2017-12-08 10:48 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2017-12-13 22:15 |
|
Articles in Press |
|
2017-12-13 22:15 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2017-12-20 18:00 |
|
Typeset the Manuscript |
|
2018-01-18 15:25 |
|
Publish the Manuscript Online |
|
2018-01-26 08:09 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Efficacy of direct-acting antiviral treatment for chronic hepatitis C: A single hospital experience
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Rena Kaneko, Natsuko Nakazaki, Risa Omori, Yuichiro Yano, Masazumi Ogawa and Yuzuru Sato |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Japan Organization of Occupational Health and Safety |
359 |
|
| Corresponding Author |
Rena Kaneko, MD, Staff Physician, Department of Gastroenterology, Japan Organization of Occupational Health and Safety Kanto Rosai Hospital, Kizukisumiyoshi 1-1, Nakahara, Kawasaki 211-8510, Japan. rena332605@kantoh.johas.go.jp |
| Key Words |
Direct-acting antivirals; Resistance-associated substitutions; Hepatitis C; Sustained viral response |
| Core Tip |
Direct-acting antivirals (DAAs) have been approved for the treatment of hepatitis C virus (HCV) genotype 1 and 2 infection in Japan since 2011. In the new era of DAA therapy, predictors who fail to respond to DAA might be compromised by resistance-associated substitutions. There have been few reports of DCV/ASV(DAA) failure because DCV/ASV is limited in Japan. Therefore, it might be important to report these cases for future research and treatment of HCV. |
| Publish Date |
2018-01-26 08:09 |
| Citation |
Kaneko R, Nakazaki N, Omori R, Yano Y, Ogawa M, Sato Y. Efficacy of direct-acting antiviral treatment for chronic hepatitis C: A single hospital experience. World J Hepatol 2018; 10(1): 88-94 |
| URL |
http://www.wjgnet.com/1948-5182/full/v10/i1/88.htm |
| DOI |
http://dx.doi.org/10.4254/wjh.v10.i1.88 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
